With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...
Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...
As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...
As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things ...
Gemma Collins has shown off a huge body transformation in the new year, revealing she's already two dress sizes smaller this ...
Medicare drug plans can now cover Eli Lilly & Co.'s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that's expected to prove a big boost for the drug company.
Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
We are a stronger company today than pre-merger,” Chief Financial Officer Shannon McCollam said on a call with analysts.